Nothing Special   »   [go: up one dir, main page]

MX9704740A - Monomeros de 3,3-(disustituido)ciclohexan-1-ol y compuestos relacionados. - Google Patents

Monomeros de 3,3-(disustituido)ciclohexan-1-ol y compuestos relacionados.

Info

Publication number
MX9704740A
MX9704740A MX9704740A MX9704740A MX9704740A MX 9704740 A MX9704740 A MX 9704740A MX 9704740 A MX9704740 A MX 9704740A MX 9704740 A MX9704740 A MX 9704740A MX 9704740 A MX9704740 A MX 9704740A
Authority
MX
Mexico
Prior art keywords
cyclohexan
disubstituted
monomers
related compounds
compounds
Prior art date
Application number
MX9704740A
Other languages
English (en)
Other versions
MXPA97004740A (es
Inventor
B Christensen Siegfried Iv
Joseph M Karpinski
Dominic M Ryan
Paul E Bender
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of MX9704740A publication Critical patent/MX9704740A/es
Publication of MXPA97004740A publication Critical patent/MXPA97004740A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/235—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring and to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C43/253—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring and to a carbon atom of a ring other than a six-membered aromatic ring containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/673—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invencion se refiere a monomeros de 3,3-(disustituido)ciclohexan-1-ol y a compuestos relacionados; a composiciones farmacéuticas que contienen estos compuestos y a su uso en el tratamiento de enfermedades alérgicas e inflamatorias, así como para inhibir la produccion del factor de necrosis tumoral (FNT).
MXPA/A/1997/004740A 1994-12-23 1997-06-23 Monomeros de 3,3-(disustituido)ciclohexan-1-ol ycompuestos relacionados MXPA97004740A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36312694A 1994-12-23 1994-12-23
US363126 1994-12-23
PCT/US1995/016840 WO1996019977A1 (en) 1994-12-23 1995-12-21 3,3-(disubstituted)cyclohexan-1-ol monomers and related compounds

Publications (2)

Publication Number Publication Date
MX9704740A true MX9704740A (es) 1997-10-31
MXPA97004740A MXPA97004740A (es) 1998-07-03

Family

ID=

Also Published As

Publication number Publication date
AU4590096A (en) 1996-07-19
CN1175209A (zh) 1998-03-04
WO1996019977A1 (en) 1996-07-04
NO972907D0 (no) 1997-06-20
BR9510289A (pt) 1997-11-11
PL321000A1 (en) 1997-11-24
CA2208445A1 (en) 1996-07-04
HUT77356A (hu) 1998-03-30
NO972907L (no) 1997-08-15
ZA9510826B (en) 1996-06-20
CZ196197A3 (cs) 1998-01-14
JPH10511664A (ja) 1998-11-10
US5866616A (en) 1999-02-02
FI972674A (fi) 1997-06-19
EP0796091A1 (en) 1997-09-24
AU711101B2 (en) 1999-10-07
NZ300524A (en) 1998-08-26
FI972674A0 (fi) 1997-06-19
EP0796091A4 (en) 1998-03-25

Similar Documents

Publication Publication Date Title
IL125282A (en) Substituted imidazole compounds, process for their preparation, pharmaceutical compositions containing them and use thereof in the preparation of medicaments for treating cytokine mediated diseases
UA48939C2 (uk) Дизаміщені фуранони, способи їх одержання, фармацевтична композиція на їх основі, спосіб лікування запального захворювання, проміжні сполуки
CA2127876A1 (en) Imidazole derivatives and their use as cytokine inhibitors
PL314300A1 (en) Peptide-type compounds and their therapeutic application as inhibitors of metalloproteinases
UA39166C2 (uk) Похідні n-гідроксисечовини, що є інгібіторами ліпоксигенази у ссавців, спосіб їх одержання і спосіб інгібування ліпоксигенази у ссавців
CZ76995A3 (en) Derivatives of 1-(oxoacetyl)pipridine-2-carboxylic acid, process of their preparation pharmaceutical composition containing thereof and their use
MX9705296A (es) Compuestos novedosos de imidazol 1,4,5-susbtituidos y el uso de los mismos para preparar composiciones para uso en terapia.
MX9604378A (es) Amidas de acido quinolin-2-carboxilico sustituidas, su preparacion y su empleo como medicamentos, asi como productos intermedios.
BG104599A (en) Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
MX9803851A (es) Compuestos macrociclicos novedosos como inhibidores de metaloproteasas.
UA72909C2 (en) Cinnamide derivatives useful in the treatment of inflammatory and immune diseases, a composition containing such derivatives and a method for the preparation of cinnamide derivatives
RU95111308A (ru) Производные 2-амино-4-фенил-4-оксомасляной кислоты, способы получения, фармацевтическая композиция
MY115211A (en) Novel amino acid derivatives, their preparation and use
BG102250A (en) The use of marigold-extracted glycosides for the treatment of psoriasis
IL126235A (en) Compounds with growth hormone releasing properties, pharmaceutical compositions comprising them and their use
AU4080097A (en) Piperazino derivatives as neurokinin antagonists
MX9708416A (es) Derivados de piperazino como antagonistas de neuroquininas.
PL346143A1 (en) Tan-1057 derivatives
MX9709361A (es) Monomero de 4.4-ciclohexan-1-ols disubstituido y compuestos relacionados.
GR3020575T3 (en) New 2-amino-5-cyano-1,4-dihydropyridines, process for their preparation and use in pharmaceutical compositions
ZA9510878B (en) 4,4-(Disubstituted)cyclohexan-1-ols monomers and related compounds
MX9704740A (es) Monomeros de 3,3-(disustituido)ciclohexan-1-ol y compuestos relacionados.
WO1996020690A3 (en) 3,3-(disubstituted)cyclohexan-1-ylidine acetate monomers and related compounds
MX9700113A (es) Amido-quinoxalindionas novedosas, su preparacion y uso.
MX9704739A (es) Monomeros de 3,3-(disustituido)ciclohexan-1-ona y compuestos relacionados.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal